Two Max Planck Postdoc Fellowships – Krembil Research Institute (Toronto, Canada)

We are currently recruiting 2 Postdoctoral Associates to hold Max Planck fellowships and conduct research at the Krembil Research Institute in Toronto, Canada.

One position is for a candidate with a neuroscience background and experience in optogenetics and fluorescence imaging: https://www.recruitingsite.com/csbsites/uhncareers/JobDescription.asp?SiteID=10031&JobNumber=854546

The second position is for a candidate with an engineering background and experience in micro-neurotechnology, especially implants: https://www.recruitingsite.com/csbsites/uhncareers/JobDescription.asp?SiteID=10031&JobNumber=854547

Please follow the links for more details and application details.

Contact information:

anett.schumacher@uhnresearch.ca

Posting end date:  2020/04/30

SickKids post-doctoral position- Immediate- Mild traumatic brain injury research

CIHR funded project- hiring post-doc immediately to study effects of glial senescence on neurons. Successful candidate will have experience and expertise in glio-neuronal co-culture techniques, molecular techniques including RNA/DNA extraction, proteomics, and background/interest in neuroscience/ neurodegenerative disease. Project will include experimental mouse model of mTBI, in vitro studies and access to a Human brain bank with history of brain trauma.

Please contact directly Principal investigator: Lili-Naz.hazrati@sickkids.ca

Neuropathology of mild traumatic brain injury (concussion) post-doc position at SickKids

NIH Funded post-doctoral position to study neuropathological changes of brain trauma in athletes. Candidate should have good knowledge of neuropathological work-up of neurodegenerative diseases in human brains. Project plans to explore and report on all neuropathological changes in a brain bank.
Contact information lili-naz.hazrati@sickkids.ca

Research Associate – University of Guelph – Khokhar laboratory

Position Title:  Research Associate 1, (Grant & Trust Professional)

Employer:  University of Guelph (Biomedical Sciences, Ontario Veterinary College)

Term: Temporary full time (24 month contract to start as soon as possible)

Hours: Full-time (35 Hours/Week)

Number of Positions: 1

Hiring Ref. Number: 2020-0027

 

N.B.:   Please read the Application Instructions before applying: https://www.uoguelph.ca/hr/careers-guelph/how-apply

 

The Khokhar Lab researches the interactions between substance use and serious mental illness, with an eye toward treatment of these disorders using a variety of behavioural and circuit-interrogation methods. The Research Associate is responsible for the following main duties:

  • conducts behavioural experiments assessing the effects of cannabinoids in a variety of animal models of addiction (e.g., withdrawal, conditioned place preference and self-administration/free-access intake) and serious mental illness (e.g., prepulse inhibition, latent inhibition);
  • provides input with respect to appropriate methodology, procedures, equipment and standards to produce required research data;
  • applies specialized knowledge and principles to review, appraise and interpret published literature, summarize research findings, and draft scientific/technical reports, manuscripts, grant proposals;
  • establishes and maintains effective relationships with external partners, which may include coordinating of project plans, presenting research findings (may include presenting findings at conferences).

 

Education, Skills, Work Experience and other Requirements:

  • Master’s degree in relevant discipline combined with at least 3-5 years of relevant research experience with behavioural paradigms including: withdrawal, conditioned place preference, self-administration/free-access intake, prepulse inhibition, latent inhibition;
  • Experience coding with behavioural control software (e.g., Med Associates or equivalent), and using behavioural assessment software (e.g., Noldus Ethovision or equivalent) and statistical analysis software packages (e.g., SPSS or R);
  • Proven ability in methodology, procedures, equipment and standards to produce required research data;
  • Proficiency in summarizing research findings, reviewing, appraising and interpreting published literature;
  • Strong attention to detail;
  • Self-motivated and able to work collaboratively within a team environment;
  • Experience with in vivo electrophysiology is considered an asset.

Salary: $54,107 – $58,600

Vacation Pay: accrual rate of 1.25 days/month

Benefits: Extended Health, Basic Life Insurance (up to specified maximums)

Location of Employer: 50 Stone Road, Guelph, ON N1G2W1

Location of Work: Guelph, ON                    

Language of Work: English

All Canadian citizens or permanent residents who qualify are invited to apply by sending their Cover Letter and CV (including list of publications demonstrating relevant experience), quoting hiring number 2020-0027, by email to careers@uoguelph.ca or by mail to the following address: 50 Stone Rd E, Guelph ON N1G 2W1 (Attention: Human Resources).

 

At the University of Guelph, fostering a culture of inclusion is an institutional imperative. The University invites and encourages applications from all qualified individuals, including from groups that are traditionally underrepresented in employment, who may contribute to further diversification of our Institution.

 

 

Posting end date: 2020/02/29

Researchers first to use ultrasound to deliver a compound that stimulates brain cell communication in mice with Alzheimer’s disease

Isabelle Aubert
Isabelle Aubert

Sunnybrook Research Institute senior scientist Dr. Isabelle Aubert and her PhD student, Kristiana Xhima, led the first study using focused ultrasound to deliver a molecule to the brain to revive the function of neurons vital to learning and memory in mice with Alzheimer’s disease.

Breakthrough targets restoring the function of neurons vital to learning and memory

Continue reading

CAN January 2020 Report on advocacy

CAN-ACN Annual Advocacy report – January 2020

Presented to SfN’s Government and Public Affairs committee by Jaideep Bains, CAN past president and GPA member.

The Canadian Association for Neuroscience has developed an active and efficient advocacy program over the last years thanks to the important support provided by the Society for Neuroscience. CAN will continue to build on the advocacy experience we have built, and, thanks to a new Memorandum of Understanding with SfN which has taken effect in July 2019, will expand its efforts in the coming years.

Our main objective in the coming months is to engage directly with elected officials, senators and parliament hill staff through the organisation of the first Canadian Parliament Hill Day, which will take place March 31st, 2020. We have hired a Public Affairs, Temple Scott Associates, with experience in organizing such events, to help with the logistic and strategic organisation of our event.
Continue reading

Slowing the progression of multiple sclerosis

Alexandre Prat  CREDIT: BONESSO-DUMAS
Alexandre Prat
CREDIT: BONESSO-DUMAS

By identifying a molecule that delays the progression of MS, CRCHUM researchers pave the way for new therapies for the nearly 77,000 Canadians living with the disease.

Over 77,000 Canadians are living with multiple sclerosis, a disease whose causes still remain unknown. Presently, they have no hope for a cure. In a study published in Science Translational Medicine, researchers at the University of Montreal Hospital Research Centre (CRCHUM) identify a molecule named ALCAM which, once blocked, delays the progression of the disease. Their results, obtained from in vitro human and in vivo mouse studies, could lead to the development of a new generation of therapies to treat this autoimmune disease. Continue reading

Cellular origins of pediatric brain tumors identified

Dr Claudia KleinmanSource: MUHC and Lady Davis Institute

A research team led by Dr. Claudia Kleinman, an investigator at the Lady Davis Institute at the Jewish General Hospital, together with  Dr. Nada Jabado, of the Research Institute of the McGill University Health Centre (RI-MUHC), and Dr. Michael Taylor, of The Hospital for Sick Children (SickKids), discovered that several types of highly aggressive and, ultimately, fatal pediatric brain tumors originate during brain development. The genetic event that triggers the disease happens in the very earliest phases of cellular development, most likely prenatal. The findings represent a significant advance in understanding these diseases, and are published in Nature Genetics. Continue reading

Activation of opioid receptor uncovered

Louis Gendron - Université de SherbrookeIn conjunction with Chinese, Belgian, German and American academic colleagues, the team of researchers from the Université de Sherbrooke (UdeS), led by the Director of the Department of Pharmacology-Physiology, Professor Louis Gendron, participated in the discovery of the binding mechanism of an important opioid receptor. The results should facilitate the development of new active substances. Opioids used today to treat severe pain can be addictive and often have significant side effects, such as nausea. The results are published in the renowned journal Science Advances. Continue reading